Mission Produce leaps 7% on top-line beat in Q3, raised Calavo synergy outlook

Mission Produce reported Q3 revenue of $450 million, up 26% year over year and well above the $280.73 million consensus, driven by a 38% increase in avocado volumes; shares rose 7%. Adjusted EPS of $0.18 missed the $0.20 estimate and declined from $0.26 a year earlier, while the company posted a $6.5 million net loss including $25.4 million of Calavo acquisition-related costs. Mission raised expected annualized Calavo synergies to more than $30 million and reaffirmed fiscal second-half adjusted EBITDA guidance of $84 million to $88 million.

Analysis

The relevant rerating mechanism is not the revenue beat; it is whether acquired distribution capacity can be rationalized faster than volume-driven price deflation erodes gross profit per case. A $30M+ annual synergy run-rate is meaningful versus Mission’s standalone earnings base, but the market should discount it until fourth-quarter EBITDA demonstrates that savings are recurring rather than purchase-accounting timing or deferred overhead. The near-term stock reaction can extend over days, yet the 1-3 month catalyst is conversion of the implied quarterly EBITDA run-rate into free cash flow after integration costs and working-capital needs.

CVGW is the cleaner read-through loser: a combined Mission-Calavo network can use freight density, procurement scale and customer overlap to compete more aggressively for retail and foodservice contracts, potentially pressuring Calavo’s realized pricing and fixed-cost absorption. Conversely, industry-wide volume growth with lower per-unit prices is not automatically negative for AVO; larger throughput can improve facility utilization and dilute logistics costs. The key risk is that avocado pricing falls faster than procurement costs and that the company chases volume through lower-margin customers, making EBITDA guidance vulnerable despite higher sales.

Consensus may be too focused on the announced synergy figure and too little on execution friction: customer concentration, retailer contract renewals, integration-related inventory disruption, and required capex can delay cash realization by two to four quarters. The thesis is falsified if fourth-quarter EBITDA lands below the guided range, if Marketing & Distribution margins fail to improve sequentially despite higher volumes, or if management reduces the synergy run-rate/timing at the next update. Over 6-18 months, successful integration could justify a structural multiple expansion; failure would leave AVO exposed as a low-margin produce distributor with a larger but less flexible cost base.

Key Decisions for Investors

• Watch-list AVO for a post-results entry rather than chase the initial move: initiate only if management confirms fourth-quarter EBITDA at or above the $53.5M midpoint and provides a dated synergy-capture schedule. Target a 6-12 month rerating on verified margin expansion; exit if adjusted EBITDA misses the low end of guidance or integration costs remain elevated beyond the next two reporting periods.
• Consider a 3-6 month relative-value position long AVO / short CVGW in equal dollar exposure after validating valuation and borrow. The trade isolates network-scale and overhead-synergy advantages from avocado-price beta; cover if CVGW demonstrates superior margin resilience or AVO’s distribution margin does not improve sequentially.
• Do not underwrite the acquisition solely from adjusted EBITDA. Before sizing, obtain pro forma net leverage, interest expense, acquisition-related capex, working-capital seasonality, and expected cash costs to achieve the $30M+ synergy target; absent those data, treat the equity as an earnings-confirmation trade rather than a fundamental core long.
• Set a sector risk trigger around a sharper-than-expected avocado-price decline: if realized prices fall materially beyond the anticipated roughly 10% decline without matching unit-volume acceleration, reduce any AVO exposure because gross-profit compression can overwhelm SG&A savings in the next quarter.